Inno Biologics Inks First Manufacturing Contract

Inno Biologics has delivered the first batch of clinical grade biopharma material made in Malaysia and entered into its first agreement to commercially manufacture biosimilars for Avesthagen Ltd., a life science company based in India.

Dr. Mohd Nazlee Kamal, group managing director of Inno Bio Ventures, said, “This accomplishment is a reflection of the propensity and capacity of the Group to pioneer Malaysia’s foray into the global biotechnology arena. To be chosen to undertake this complex project in a highly competitive business environment, and to deliver the project with quality, value and in a timely manner, is a testament to the capability and expertise of our young team.”

“We chose to collaborate with Inno Bio and our faith and confidence has been repaid with the commitment and professionalism and proof of this is the timely delivery of the batch of clinical grade material,” said Avesthagen’s founder, chairperson and managing director, Dr. Villoo Morawala-Patell. “Avesthagen has a rich pipeline of biosimilars, four of which are already through the RCGM (Indian Regulatory body) for conducting clinical trials. We foresee Inno Bio playing an important role in meeting Avesthagen’s goals in getting our biosimilars quickly to the market.”